Westerman, Mark

Immunoassay for human serum hepcidin

Ganz, T., Olbina, G., Girelli, D., Nemeth, E., & Westerman, M. (2008) · Blood

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 688

Suppression of iron-regulatory hepcidin by vitamin D

Bacchetta, J., Zaritsky, J. J., Sea, J. L., Chun, R. F., Lisse, T. S., Zavala, K., Nayak, A., Wesseling-Perry, K., Westerman, M., Hollis, B. W., et al. (2014) · Journal of the American Society of Nephrology

Iron Metabolism and DisordersVitamin D Research Studies

Cited by 350

Testosterone Suppresses Hepcidin in Men: A Potential Mechanism for Testosterone-Induced Erythrocytosis

Bachman, E., Feng, R., Travison, T., Li, M., Olbina, G., Ostland, V., Ulloor, J., Zhang, A., Basaria, S., Ganz, T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism

Iron Metabolism and DisordersHormonal and reproductive studies

Cited by 247

Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project

Piperno, A., Galimberti, S., Mariani, R., Pelucchi, S., Ravasi, G., Lombardi, C., Bilo, G., Revera, M., Giuliano, A., Faini, A., et al. (2011) · Blood

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 151

Reduction of serum hepcidin by hemodialysis in pediatric and adult patients

Zaritsky, J., Young, B., Gales, B., Wang, H.-J., Rastogi, A., Westerman, M., Nemeth, E., Ganz, T., & Salusky, I. B. (2010) · Clinical Journal of the American Society of Nephrology

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 107

Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin

Ruivard, M., Lainé, F., Ganz, T., Olbina, G., Westerman, M., Nemeth, E., Rambeau, M., Mazur, A., Gerbaud, L., Tournilhac, V., et al. (2009) · Journal of Hepatology

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 89

Combination therapy with a T mprss6 RNA i‐therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β‐thalassemia intermedia

Schmidt, P. J., Racie, T., Westerman, M., Fitzgerald, K., Butler, J. S., & Fleming, M. D. (2015) · American Journal of Hematology

Iron Metabolism and DisordersHemoglobinopathies and Related Disorders

Cited by 77

Iron-deficiency anemia in Castleman disease: implication of the interleukin 6/hepcidin pathway

Arlet, J.-B., Hermine, O., Darnige, L., Ostland, V., Westerman, M., Badoual, C., Pouchot, J., & Capron, L. (2010) · PEDIATRICS

Iron Metabolism and DisordersTrace Elements in Health

Cited by 46

Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial

Doyle, M. K., Rahman, M. U., Frederick, B., Birbara, C. A., de Vries, D., Toedter, G., Wu, X., Chen, D., Ranganath, V. K., Westerman, M. E., et al. (2013) · Rheumatology

Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research

Cited by 40

Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency

Heeney, M. M., Guo, D., De Falco, L., Campagna, D. R., Olbina, G., Kao, P. P.-C., Schmitz-Abe, K., Rahimov, F., Gutschow, P., Westerman, K., et al. (2018) · Blood

Iron Metabolism and DisordersNeurological diseases and metabolism

Cited by 25